The startup develops bio protection technology that utilizes revolutionary antimicrobial particles to convert various materials and surfaces into effective antimicrobial agents. This technology provides users with durable and safe protection against harmful microorganisms, enhancing hygiene in diverse applications.
Funding
$3.6M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Founders
Product
Problem
Healthcare-associated infections (HAIs) and device-related infections pose a significant threat in medical, dental, and industrial settings. Traditional antimicrobial solutions often involve leaching or release of chemicals, leading to short-term efficacy and potential toxicity. The rise of antimicrobial resistance (AMR) further complicates the management of microbial contamination on surfaces and within materials.
Solution
Nobio develops antimicrobial technology that integrates non-leaching, covalently-bound antimicrobial particles into various materials, creating long-lasting bioprotection against bacteria and viruses. These particles exert electrostatic stress on microbes, causing their breakdown without releasing chemicals or toxins into the environment. The technology can be applied to a range of products, including dental restoratives, medical devices, and industrial equipment, providing durable and safe antimicrobial properties. Nobio partners with industry leaders to incorporate its technology into existing products and develop new antimicrobial solutions.
Target Audience
Target customers include manufacturers of medical devices, dental products, and industrial equipment seeking to enhance their products with durable and safe antimicrobial properties.
Features
- Non-leaching antimicrobial particles covalently bound to the material for long-lasting protection
- Broad-spectrum efficacy against common pathogens, including multi-drug resistant bacteria
- Demonstrated ability to reduce bacteria by more than 6 logs after 6 months of aging
- Integration into various materials, including polymers, composites, and coatings
- Customizable solutions tailored to specific product requirements and applications
- ISO 13485:2016 certification for design, development, and manufacturing of medical devices
- Anti-biofilm effect demonstrated in in-vivo clinical studies